CIK: 0001637359
Total reported value
$163.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Juno Therapeutics | Stock-Other | 28.17% | — | — | |
| 2 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 25.83% | — | — | |
| 3 | EGLTEUR | Egalet CORP | Stock-Other | 16.79% | — | — | |
| 4 | FGENEUR | Fibrogen INC | Stock-Other | 12.99% | — | — | |
| 5 | ✓ | Nabriva Therapeutics AG | Stock-Other | 6.17% | — | — | |
| 6 | ✓ | Essa Pharma INC | Stock-Other | 3.56% | — | — | |
| 7 | PIRSEUR | Pieris Pharmaceuticals INC | Stock-Other | 2.58% | — | -18.29% | |
| 8 | PRTOEUR | Proteon Therapeutics INC | Stock-Other | 1.78% | — | — | |
| 9 | DRNAUSD | Dicerna Pharmaceuticals INC | Stock-Other | 1.00% | — | — | |
| 10 | EDIT | Editas Medicine INC | Stock-Other | 0.68% | — | -36.99% | |
| 11 | CBAYUSD | Cymabay Therapeutics INC | Stock-Other | 0.45% | — | -50.26% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | EGLTEUR | Egalet CORP | +6.2% | — | Unchanged |
| 2 | FGENEUR | Fibrogen INC | +3% | — | Unchanged |
| 3 | DRNAUSD | Dicerna Pharmaceuticals INC | +0.5% | — | Unchanged |
| 4 | PRTOEUR | Proteon Therapeutics INC | +0.3% | — | Unchanged |
| 5 | PIRSEUR | Pieris Pharmaceuticals INC | -0.1% | -18.29% | Trim |
| 6 | ✓ | Essa Pharma INC | -0.2% | — | Unchanged |
| 7 | ✓ | Nabriva Therapeutics AG | -0.2% | — | Unchanged |
| 8 | CBAYUSD | Cymabay Therapeutics INC | -0.3% | -50.26% | Trim |
| 9 | PRTKEUR | Paratek Pharmaceuticals INC | -1% | — | Unchanged |
| 10 | EDIT | Editas Medicine INC | -1.2% | -36.99% | Trim |
| 11 | ✓ | Juno Therapeutics | -6.9% | — | Unchanged |